Julia Dooley
About Julia Dooley
Julia Dooley is a Principal Scientist currently at MOMA Therapeutics, with extensive experience in oncology and biochemistry across several prominent research institutions, including Novartis and Pfizer.
Current Role at MOMA Therapeutics
Julia Dooley serves as a Principal Scientist at MOMA Therapeutics, a position she has held since 2021. In this role, she focuses on advancing therapeutic strategies and contributes to the development of innovative treatments. Her expertise in oncology and biochemistry supports the company's mission to enhance patient outcomes through targeted therapies.
Previous Experience at Novartis Institutes for BioMedical Research
Julia Dooley worked at Novartis Institutes for BioMedical Research (NIBR) in various capacities. She began as a Scientist I in Oncology Biochemistry and Biophysics from 2012 to 2015, followed by a role as Scientist II in Oncology Biological Chemistry from 2015 to 2018. She later advanced to Principal Scientist I in Oncology Biological Chemistry, serving from 2018 to 2021. Her tenure at NIBR spanned nearly a decade and involved significant contributions to oncology research.
Experience at Radius Health, Inc.
Before her time at Novartis, Julia Dooley worked as a Research Associate at Radius Health, Inc. from 2007 to 2010. During this period, she gained valuable experience in research methodologies and contributed to projects focused on health innovations. This role laid the groundwork for her future positions in the biopharmaceutical industry.
Role at Pfizer
Julia Dooley held the position of Senior Associate Scientist in Inflammation and Autoimmunity at Pfizer from 2010 to 2012. In this role, she contributed to research initiatives aimed at understanding inflammatory diseases and developing therapeutic solutions. Her experience at Pfizer further enhanced her expertise in the biopharmaceutical sector.
Education and Academic Background
Julia Dooley earned her Bachelor of Science degree in Biochemistry from Boston College, completing her studies from 2003 to 2007. This educational foundation provided her with a strong understanding of biochemical principles, which she has applied throughout her career in various scientific roles.